Top marks for CEO coaching in collaboration between Almi and SmiLe

The third round of SmiLe´s CEO group coaching has now been completed and has consistently garnered top marks from participants. The program is held by Almi Företagspartner in collaboration with SmiLe as part of SmiLe's leadership program. The next round will begin this autumn.

 

The collaboration with SmiLe means that the CEO group only includes business leaders from SmiLe’s life science companies. The CEO group meets up on seven occasions. In line with the concept, participants coach one another within given frameworks using structured coaching. Under the guidance of Tina Karlsson from Almi Företagspartner Skåne, frank discussions are conducted in an open atmosphere, with a generous give and take approach. 

 

“Each CEO group is always struck by how powerful our methodology is with respect to encouraging growth as business leaders. They come to realize that they need to begin within themselves, rather than trying to live up to a general image of how a CEO behaves. They gain self-understanding and develop new confidence in their role. This group found that sharing challenges and giving each other advice was both fun and highly stimulating. They’ve decided to continue meeting in this way, even after the program ends,” says Tina Karlsson from Almi Företagspartner Skåne.

 

To date, over 20 business leaders from SmiLe companies have had the opportunity to grow through CEO groups. The participants realize over the course of program that they all face similar challenges. These include how an organization should be structured, corporate culture and leadership, as well as matters related to pricing, marketing and communication.

 

“We’re extremely pleased to be able to offer this exclusive collaboration for CEO groups. The programs include participants from current incubator companies, as well as from our alumni companies, which adds an extra dimension to the discussions. Since everyone is active in the same industry, they share a common frame of reference, which creates relevance. Our People&Culture offering at SmiLe also includes CEO lunches with various themes for discussion, as well as workshops focused on relevant subjects, such as recruitment, feedback training, team building and dedicated training programs,” says Ebba Fåhraeus, CEO of SmiLe Incubator.

 

 

For more information: Ebba Fåhraeus, CEO of SmiLe Incubator, +46 (0)734000433, ebba@smileincubator.life

 

Reviews from participants:

 

“Great to discuss your issues in a ‘safe’ environment with people who are, or have been, in the same situation.”

“We had enough time to get down to the roots of everyone´s challenges.”

“I wish the program lasted longer.”

 

 

About the companies:

Acorai, CEO Filip Peters – Acorai is redefining heart failure monitoring by enabling non-invasive intracardiac pressure monitoring to help reduce heart failure re-hospitalizations and mortality rates. The company is backed by German pharmaceutical company Bayer, and currently has multiple collaboration partnerships with some of the world’s leading hospitals. acorai

Asgard Therapeutics, CEO Cristiana Pires – Asgard Therapeutics is exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses. Backed by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden, Asgard aims to build a pipeline of personalized cancer immunotherapies optimized to each unique patient. asgardthx

 

Diagonal Bio, CEO Jack Egelund Madsen – The company has made significant progress in the development towards a fast, simple and reliable diagnosis of several diseases simultaneously and / or several patients at the same time, where the technology is based on the company's Panviral diagnostics platform. Diagonal Bio is listed on the Nasdaq First North Growth Market. diagonalbio

 

Medilevel, CEO Patrik Borneson – Medilevel has developed a communication tool for titrating medicine. It can easily be adapted to a wide range of different medications. It will increase patient involvement and compliance, decrease side effects and the number of patient appointments. The company has products on the market. medilevel

 

Saveggy, CEO Vahid Sohrabpour – Saveggy develops a biobased coating as an alternative to protective plastic currently used to prolong the shelf life of fruit and vegetables. Saveggy’s eco-friendly and eatable solution, based on research from Lund University, gives the vegetable a coating that provides the same extended shelf life as plastic. Recently, the company recieved funding in an investment-round led by SmiLe Incubator’s angel investment company, SmiLe Inject Capital. saveggy

 

Sorbus Biomedical, CEO Roger Rönn – The aim of Sorbus Biomedical is to become a driving force in biotech by developing new innovative tools for improving cell cultivation. Having established a development site for innovation and testing at SmiLe Incubator, Sorbus Biomedical is currently undergoing it’s verification process and will look towards expanding its team and operations in the second half of 2022. sorbusbiomedical 

 

About Almi: Almi offers loans to companies with growth potential and assists in their business development. The offering applies to both startups and established companies. The subsidiary Almi Invest provides venture capital for early-stage, emerging companies with high growth potential and a scalable business concept.

---

---